Literature DB >> 1080631

Parenteral aspirin produces and enhances gastric mucosal lesions and bleeding in rats.

J C Meeroff, G Paulsen, P H Guth.   

Abstract

The effect of parenteral sodium acetylsalicylate (Na ASA) on the development of gastric mucosal lesions and bleeding was studied in control rats and in rats subjected to cold-restraint stress. Although both doses of Na ASA studied, 15 and 60 mg/kg intraperitoneally, alone resulted in lesion formation, only with the larger dose did this reach the level of statistical significance. However both doses of Na ASA alone significantly increased blood loss as measured by a decrease in hematocrit value. The administration of Na ASA 15 MG/kg intraperitoneally to animals subjected to cold-restraint significantly increased blood loss, but not lesion formation, while the larger dose of Na ASA significantly increased both parameters. Thus parenteral aspirin not only can cause gastric mucosal damage and bleeding, but it can enhance lesion formation and blood loss produced by cold-restraint. Two mechanisms may be involved: a smaller dose of Na ASA significantly affecting hemostasis but a larger dose being required for gastric mucosal damage.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080631     DOI: 10.1007/bf01070953

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  24 in total

1.  EFFECT OF ASPIRIN ON GASTRIC SECRETION.

Authors:  A LYNCH; H SHAW; G W MILTON
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  Gastric secretion in relation to gastrointestinal bleeding from salicylate compounds.

Authors:  E I WINKELMAN; W H SUMMERSKILL
Journal:  Gastroenterology       Date:  1961-01       Impact factor: 22.682

3.  Fecal blood loss produced by oral and intravenous administration of various salicylates.

Authors:  M I GROSSMAN; K K MATSUMOTO; R J LICHTER
Journal:  Gastroenterology       Date:  1961-03       Impact factor: 22.682

4.  Gastrointestinal haemorrhage and salicylates.

Authors:  A S ALVAREZ; W H SUMMERSKILL
Journal:  Lancet       Date:  1958-11-01       Impact factor: 79.321

5.  Role of gastric acid in aspirin-induced gastric irritation in the rat.

Authors:  D A Brodie; B J Chase
Journal:  Gastroenterology       Date:  1967-10       Impact factor: 22.682

6.  Fluid produced by the gastric mucosa during damage by acetic and salicylic acids.

Authors:  H W Davenport
Journal:  Gastroenterology       Date:  1966-04       Impact factor: 22.682

7.  Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate.

Authors:  D A Brodie; K F Hooke
Journal:  Am J Dig Dis       Date:  1971-11

8.  Aspirin-induced occult gastrointestinal blood loss. Local versus systemic effects.

Authors:  J R Leonards; G Levy
Journal:  J Pharm Sci       Date:  1970-10       Impact factor: 3.534

9.  The effect of salicylates on the hemostatic properties of platelets in man.

Authors:  H J Weiss; L M Aledort; S Kochwa
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  Failure of intravenous aspirin to increase gastrointestinal blood loss.

Authors:  A R Cooke; K Goulston
Journal:  Br Med J       Date:  1969-08-09
View more
  4 in total

1.  Letter: Gastrotoxic effect of parenteral aspirin.

Authors:  D J St John; N D Yeomans
Journal:  Am J Dig Dis       Date:  1976-09

2.  The role of aspirin in gastric ulceration . Some factors involved in the development of gastric mucosal damage induced by aspirin in rats exposed to various stress conditions.

Authors:  K D Rainsford
Journal:  Am J Dig Dis       Date:  1978-06

3.  Enhancement by intracerebroventricular thyrotropin-releasing hormone of indomethacin-induced gastric lesions in the rat.

Authors:  M Maeda-Hagiwara; H Watanabe; K Watanabe
Journal:  Br J Pharmacol       Date:  1983-12       Impact factor: 8.739

4.  IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection.

Authors:  Jon N Buzzelli; Heather V Chalinor; Daniel I Pavlic; Philip Sutton; Trevelyan R Menheniott; Andrew S Giraud; Louise M Judd
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.